This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1985-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-2001
Title: Toshitaka Manda: Innovator in Vascular-Permeability Suppressants
Introduction
Toshitaka Manda is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of vascular-permeability suppressants. With a total of 2 patents to his name, Manda's work has implications for anti-inflammatory and anti-tumor therapies.
Latest Patents
Manda's latest patents include innovative compounds that serve as vascular permeability suppressants. One of his notable inventions is an oxaspirooctane derivative designed to enhance anti-inflammatory activity. Additionally, he has developed novel clavulone derivatives that exhibit excellent anti-tumor activity, making them valuable as therapeutic agents.
Career Highlights
Toshitaka Manda is currently associated with Fujisawa Pharmaceutical Company, Ltd. His work at this esteemed organization has allowed him to focus on groundbreaking research and development in the pharmaceutical industry. His contributions have been instrumental in advancing medical treatments.
Collaborations
Manda has collaborated with esteemed colleagues such as Kyoichi Shimomura and Fusako Nishigaki. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Toshitaka Manda's contributions to the field of pharmaceuticals, particularly in vascular-permeability suppressants, highlight his role as a significant inventor. His work continues to influence the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile